Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice

被引:196
作者
Kreijtz, J. H. C. M. [1 ]
Bodewes, R. [1 ]
van Amerongen, G. [1 ]
Kuiken, T. [1 ]
Fouchier, R. A. M. [1 ]
Osterhaus, A. D. M. E. [1 ]
Rimmelzwaan, G. F. [1 ]
机构
[1] Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands
关键词
cross-protection; CTL; influenza;
D O I
10.1016/j.vaccine.2006.08.036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to assess the level of protection against a lethal influenza virus infection provided by a primary infection with a virus strain of another subtype, C57BL/6 mice were infected with the sublethal influenza virus X-31 (H3N2) and subsequently challenged with the lethal strain A/PR/8/34 (H1N1). The outcome of the challenge infection was compared with that in mice that did not experience an infection with influenza virus X-31 prior to the challenge infection. The X-31 experienced mice cleared the infection with influenza virus A/PR/8/34 in ail accelerated fashion, displayed less clinical signs and a reduction of lesions in the lungs resulting in improved survival rates of these mice compared to the naive mice. The improved outcome of the challenge infection with influenza virus A/PR/8/34 in the X-31 experienced mice correlated with priming for anamnestic virus-specific CD8(+) cytotoxic T lymphocyte (CTL) responses as was demonstrated by the detection of CTL specific for the H-2D(b) restricted NP366-374 epitope that was shared by the influenza viruses X-31 and A/PR/8/34. Thus previous exposure to influenza A viruses affords partial protection against infection in the absence of virus-neutralizing antibodies specific for the hemagglutinin and the neuraminidase. The implications of these observations are discussed in the light of the current pandemic threat and development of vaccines that aim at the induction of virus-specific CTL. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:612 / 620
页数:9
相关论文
共 51 条
[11]   Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus [J].
Claas, ECJ ;
Osterhaus, ADME ;
van Beek, R ;
De Jong, JC ;
Rimmelzwaan, GF ;
Senne, DA ;
Krauss, S ;
Shortridge, KF ;
Webster, RG .
LANCET, 1998, 351 (9101) :472-477
[12]   Respiratory vaccination of mice against influenza virus: Dissection of T- and B-cell priming functions [J].
Coleclough, C ;
Sealy, R ;
Surman, S ;
Marshall, DR ;
Hurwitz, JL .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2005, 62 :73-83
[13]   A pandemic warning? [J].
deJong, JC ;
Claas, ECJ ;
Osterhaus, ADME ;
Webster, RG ;
Lim, WL .
NATURE, 1997, 389 (6651) :554-554
[14]   CYTOTOXIC T-CELL RESPONSES IN MICE INFECTED WITH INFLUENZA AND VACCINIA VIRUSES VARY IN MAGNITUDE WITH H-2 GENOTYPE [J].
DOHERTY, PC ;
BIDDISON, WE ;
BENNINK, JR ;
KNOWLES, BB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (02) :534-543
[15]   CLEARANCE OF INFLUENZA-VIRUS RESPIRATORY-INFECTION IN MICE LACKING CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED CD8+ T-CELLS [J].
EICHELBERGER, M ;
ALLAN, W ;
ZIJLSTRA, M ;
JAENISCH, R ;
DOHERTY, PC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (04) :875-880
[16]  
Epstein SL, 1997, J IMMUNOL, V158, P1222
[17]   Virus-specific CD8+ T cells in primary and secondary influenza pneumonia [J].
Flynn, KJ ;
Belz, GT ;
Altman, JD ;
Ahmed, R ;
Woodland, DL ;
Doherty, PC .
IMMUNITY, 1998, 8 (06) :683-691
[18]   MICRONEUTRALIZATION TEST FOR INFLUENZA-A AND INFLUENZA-B AND PARA-INFLUENZA-1 AND PARAINFLUENZA-2 VIRUSES THAT USES CONTINUOUS CELL-LINES AND FRESH SERUM ENHANCEMENT [J].
FRANK, AL ;
PUCK, J ;
HUGHES, BJ ;
CATE, TR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1980, 12 (03) :426-432
[19]   Selective expansion of cross-reactive CD8+ memory T cells by viral variants [J].
Haanen, JBAG ;
Wolkers, MC ;
Kruisbeek, AM ;
Schumacher, TNM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (09) :1319-1328
[20]   Avian influenza A (H5N1) in 10 patients in Vietnam. [J].
Hien, TT ;
Liem, NT ;
Dung, NT ;
San, LT ;
Mai, PP ;
Chau, NVV ;
Suu, PT ;
Dong, VC ;
Mai, LTQ ;
Thi, NT ;
Khoa, DB ;
Phat, LP ;
Truong, NT ;
Long, HT ;
Tung, CV ;
Giang, LT ;
Tho, ND ;
Nga, LH ;
Tien, NTK ;
San, LH ;
Tuan, LV ;
Dolecek, C ;
Thanh, TT ;
de Jong, M ;
Schultsz, C ;
Cheng, P ;
Lim, W ;
Horby, P ;
Farrar, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1179-1188